PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Misconceptions keep some cancer patient populations from benefitting from hormone therapy

New survey demonstrates need for additional clinician training because many patients with a history of endometrial or epithelial ovarian cancer are still not being prescribed hormone because of safety concerns

2025-09-10
(Press-News.org) CLEVELAND, Ohio (September 10, 2025)—Despite evidence suggesting the safety of hormone therapy for patients with a history of low-grade endometrial or epithelial ovarian cancer, a new survey shows that many gynecologists and some gynecologic oncologists are still uncomfortable prescribing the therapy for this patient population. This indicates a need for more clinician education to help overcome lingering misconceptions. Results of the survey are published online today in Menopause, the journal of The Menopause Society.

Although most patients with gynecologic cancers are postmenopausal, it is estimated that 40% of these patients are premenopausal or perimenopausal at the time of diagnosis. Many patients undergoing surgery for a gynecologic malignancy will require a bilateral oophorectomy as part of their treatment. In addition, both chemotherapy and radiotherapy put women at risk of decreased ovarian function.

Thanks to improvements in cancer therapies, it is important to consider the long-term effects of primary ovarian insufficiency and hormone deprivation in premenopausal patients with gynecologic cancer. Estrogen therapy, however, has historically been underused in this population because of provider concerns primarily regarding cancer recurrence.

In 2020, the Society of Gynecologic Oncology (SGO) released a statement that was affirmed by The Menopause Society to help guide the use of hormone therapy in patients with gynecologic cancer. Since that time, there is no known publication of statistics relative to the effect on the frequency of practitioners prescribing hormones for this population.

That’s why this new web-based survey of 293 members of the SGO and the American College of Obstetricians and Gynecologists was undertaken to explore and define the use of estrogen therapy in women with a history of gynecologic cancer. Some of the highlighted results of the survey include

63.82% of respondents prescribe estrogen therapy to patients with endometrial cancer 65.19% of respondents feel comfortable prescribing estrogen to patients with epithelial ovarian cancer 96.8% of respondents are comfortable prescribing estrogen for patients with cervical cancer Prescribing patterns differed significantly based on sex, job title, and years in practice. The data suggest that benign gynecology care professionals and those with less clinical experience are more likely to hold misconceptions around hormone safety.

The respondents were also asked about their preferred estrogen therapy alternatives. Selective serotonin reuptake inhibitors were the most frequently selected (88.4%), followed by gabapentin (58%), and neurokinin-3 antagonists (46.4%).

Studies demonstrate that hormone therapy is a highly effective and safe (for most women) treatment to manage bothersome menopause symptoms that can greatly affect a woman’s quality of life. The most common reason for not prescribing estrogen therapy in patients with a history of gynecologic cancer was the belief that the risks outweighed the benefits. Although this may be true for certain cancers, it is not for all.

Survey results are published in the article “Estrogen therapy in patients with gynecologic cancer: a survey of gynecologists and oncologists in the United States.”

“Treatment for gynecologic cancers often accelerates the onset of menopause and contributes to more severe symptoms in this population. Hormone therapy is the most effective treatment for the management of vasomotor symptoms and genitourinary syndrome of menopause. Recognizing when hormone therapy can be safely used will have a beneficial effect on overall well-being and health,” says Dr. Monica Christmas, associate medical director for The Menopause Society.

For more information about menopause and healthy aging, visit www.menopause.org.

The Menopause Society is dedicated to empowering healthcare professionals and providing them with the tools and resources to improve the health of women during the menopause transition and beyond. As the leading authority on menopause since 1989, the nonprofit, multidisciplinary organization serves as the independent, evidence-based resource for healthcare professionals, researchers, the media, and the public and leads the conversation about improving women’s health and healthcare experiences. To learn more, visit menopause.org.

END


ELSE PRESS RELEASES FROM THIS DATE:

Predicting the green glow of aurorae on the red planet

2025-09-10
Planetary scientists believe they can now predict the green glow of an aurora in the night sky above Mars, and they have the images to prove it. The first observations of a visible-light aurora from the surface of the Red Planet were made by NASA’s Perseverance Mars rover in 2024. Now, presenting at the Europlanet Science Congress–Division of Planetary Science (EPSC–DPS) joint meeting in Helsinki this week, Dr Elise Wright Knutsen of the University of Oslo will reveal a second snapshot of the aurora by Perseverance and, more importantly, the tools to predict when an aurora will occur on Mars. "The fact that we captured the aurora again demonstrates that our method ...

Giant DNA discovered hiding in your mouth

2025-09-10
Researchers including those at the University of Tokyo have made a surprising discovery hiding in people’s mouths: Inocles, giant DNA elements that had previously escaped detection. These appear to play a central role in helping bacteria adapt to the constantly changing environment of the mouth. The findings provide fresh insight into how oral bacteria colonize and persist in humans, with potential implications for health, disease and microbiome research. You might think that modern medical science knows everything there is to know about ...

Children lose muscle during early cancer treatment — new ECU study warns of a hidden danger to recovery 

2025-09-10
Children lose muscle during early cancer treatment — new ECU study warns of a hidden danger to recovery    New research from the Exercise Medicine Research Institute at Edith Cowan University (ECU) has highlighted that children undergoing cancer treatment often lose skeletal muscle at a time when they should be rapidly gaining it, a loss that could increase treatment complications and raise the risk of long-term health problems.  “Both the cancer itself and the cancer treatment can cause muscle loss in ...

World-first koala chlamydia vaccine approved

2025-09-10
World-first koala chlamydia vaccine approved In a world first, a vaccine has been approved to protect Australia’s endangered koalas from infection and death caused by chlamydia. Developed by the University of the Sunshine Coast, the vaccine’s approval by Australia’s veterinary medicine regulator is a major step in the fight against one of the greatest threats to the long-term survival of the nation’s iconic marsupial.  Led by Professor of Microbiology Peter Timms,  University of the Sunshine Coast researchers have spent more than 10 years developing the vaccine to protect ...

Taking the pulse of digital health in Asia

2025-09-10
HONG KONG (9 September 2025)—Advancing digital healthcare innovation across the region is the key driver behind Digital Health Asia 2025, organised by Times Higher Education (THE) in partnership with City University of Hong Kong (CityUHK) and the Institute of Digital Medicine (IDM).   Digital Health Asia, from 8 to 10 September, has brought together over 420 delegates from 17 regions, including leaders from academia, healthcare, government, and industry, to foster collaboration and drive progress in digital health.   “Digital Health Asia 2025 is more than just a conference. It is a celebration of the spirit of collaboration,” ...

Even healthy children can be severely affected by RSV

2025-09-10
It is not only premature babies and children with underlying diseases who suffer from serious respiratory syncytial virus (RSV) infections. Even healthy, full-term babies are at significant risk of intensive care or prolonged hospitalisation – especially during the first three months of life. This is according to a comprehensive registry study from Karolinska Institutet in Sweden published in The Lancet Regional Health – Europe. RSV is a common cause of respiratory infections in young children and accounts for around 245,000 ...

Keto diet linked to reduced depression symptoms in college students

2025-09-10
[Embargoed until 8 p.m. ET Sept. 9, 2025 (1 a.m. UK Sept. 10, 2025), coinciding with publication in Translational Psychiatry] COLUMBUS, Ohio – A new study shows an association between at least 10 weeks of following a well-formulated ketogenic diet and a roughly 70% decrease in depression symptoms among a small group of college students. Beyond the reduction in self-reported and clinician rated depression, the students’ global well-being increased nearly three-fold and their performance improved on several cognitive tasks. All but one participant ...

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

2025-09-10
Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical cancers caused by HPV, there is no screening test for HPV-associated head and neck cancers. This means that patients are usually diagnosed after a tumor has grown to billions of cells in size, causing symptoms and spreading to lymph nodes. Screening methods that can detect these cancers much earlier could mean earlier treatment interventions for patients.  In a new federally funded study, published in the Journal of the National Cancer Institute, Mass General Brigham researchers ...

Odds of dementia strongly linked to number of co-existing mental health disorders

2025-09-09
The odds of developing dementia are strongly linked to the number of co-existing mental health disorders, rising from twice as high for one disorder to 11 times as high for four or more, finds research published in the open access journal BMJ Mental Health. In particular, the combination of concurrent mood and anxiety disorders is linked to odds of  dementia of up to 90%, the findings indicate. Psychiatric disorders, such as depression, anxiety, and bipolar disorder, have been individually associated with an increased risk ...

Large social and economic inequalities persist among UK doctors

2025-09-09
Large social and economic inequalities persist among UK doctors, with those from a professional background 6 times more likely to become a medical practitioner than those from a working class background, reveals a 10 year study, published in the open access journal BMJ Open. Greater efforts are needed to boost the social mobility of medical school applicants and better understand the effects of these inequalities on patient care, say the researchers. National data from 2014 show that only 4% of practising doctors came from lower-income working class backgrounds. And despite concerted efforts over the past 20 years to ...

LAST 30 PRESS RELEASES:

Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date

AI and omics unlock personalized drugs and RNA therapies for heart disease

2023 ocean heatwave ‘unprecedented but not unexpected’

Johns Hopkins researchers develop AI to predict risk of US car crashes

New drug combination offers hope for men with advanced prostate cancer

New discovery finds gene converts insulin-producing cells into blood-sugar boosters

Powerful and precise multi-color lasers now fit on a single chip

Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

[Press-News.org] Misconceptions keep some cancer patient populations from benefitting from hormone therapy
New survey demonstrates need for additional clinician training because many patients with a history of endometrial or epithelial ovarian cancer are still not being prescribed hormone because of safety concerns